191 related articles for article (PubMed ID: 33466525)
1. A Prospective Multicenter Cohort Surveillance Study of Invasive Aspergillosis in Patients with Hematologic Malignancies in Greece: Impact of the Revised EORTC/MSGERC 2020 Criteria.
Siopi M; Karakatsanis S; Roumpakis C; Korantanis K; Sambatakou H; Sipsas NV; Tsirigotis P; Pagoni M; Meletiadis J
J Fungi (Basel); 2021 Jan; 7(1):. PubMed ID: 33466525
[TBL] [Abstract][Full Text] [Related]
2. Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy.
Acet-Öztürk NA; Ömer-Topçu D; Vurat-Acar K; Aydın-Güçlü Ö; Pınar İE; Demirdöğen E; Görek-Dilektaşlı A; Kazak E; Özkocaman V; Ursavas A; Akalın H; Özkalemkaş F; Ener B; Ali R
J Mycol Med; 2022 Nov; 32(4):101304. PubMed ID: 35738036
[TBL] [Abstract][Full Text] [Related]
3. Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan.
Mikulska M; Furfaro E; De Carolis E; Drago E; Pulzato I; Borghesi ML; Zappulo E; Raiola AM; Grazia CD; Del Bono V; Cittadini G; Angelucci E; Sanguinetti M; Viscoli C
Med Mycol; 2019 Nov; 57(8):987-996. PubMed ID: 30753590
[TBL] [Abstract][Full Text] [Related]
4. Invasive Aspergillosis among Haematological Malignancy Patients in Ghana: A Pilot Study on Prevalence and Antifungal Prophylaxis at the National Referral Hospital.
Ocansey BK; Otoo B; Gbadamosi H; Opintan JA; Dei-Adomakoh Y; Kosmidis C; Denning DW
West Afr J Med; 2023 Jun; 40(6):613-618. PubMed ID: 37390225
[TBL] [Abstract][Full Text] [Related]
5. Impact of the revised (2008) EORTC/MSG definitions for invasive fungal disease on the rates of diagnosis of invasive aspergillosis.
Tsitsikas DA; Morin A; Araf S; Murtagh B; Johnson G; Vinnicombe S; Ellis S; Suaris T; Wilks M; Doffman S; Agrawal SG
Med Mycol; 2012 Jul; 50(5):538-42. PubMed ID: 22074309
[TBL] [Abstract][Full Text] [Related]
6. Airborne fungal spores and invasive aspergillosis in hematologic units in a tertiary hospital during construction: a prospective cohort study.
Park JH; Ryu SH; Lee JY; Kim HJ; Kwak SH; Jung J; Lee J; Sung H; Kim SH
Antimicrob Resist Infect Control; 2019; 8():88. PubMed ID: 31161035
[TBL] [Abstract][Full Text] [Related]
7. Combining Aspergillus mitochondrial and ribosomal QPCR, in addition to galactomannan assay, for early diagnosis of invasive aspergillosis in hematology patients.
Bellanger AP; Millon L; Berceanu A; Grenouillet F; Grenouillet FE; Larosa F; Deconinck E
Med Mycol; 2015 Sep; 53(7):760-4. PubMed ID: 26162471
[TBL] [Abstract][Full Text] [Related]
8. The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis.
Cruciani M; White PL; Mengoli C; Löffler J; Morton CO; Klingspor L; Buchheidt D; Maertens J; Heinz WJ; Rogers TR; Weinbergerova B; Warris A; Lockhart DEA; Jones B; Cordonnier C; Donnelly JP; Barnes RA;
J Antimicrob Chemother; 2021 Feb; 76(3):635-638. PubMed ID: 33374010
[TBL] [Abstract][Full Text] [Related]
9. The effect of clinical characteristics on the performance of galactomannan and PCR for the diagnosis of invasive aspergillosis in febrile neutropenic patients.
Oz Y; Aslan M; Aksit F; Metintas S; Gunduz E
Mycoses; 2016 Feb; 59(2):86-92. PubMed ID: 26627843
[TBL] [Abstract][Full Text] [Related]
10. Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.
Eigl S; Hoenigl M; Spiess B; Heldt S; Prattes J; Neumeister P; Wolfler A; Rabensteiner J; Prueller F; Krause R; Reinwald M; Flick H; Buchheidt D; Boch T
Med Mycol; 2017 Jul; 55(5):528-534. PubMed ID: 27744310
[TBL] [Abstract][Full Text] [Related]
11. Blood Mucorales PCR to track down
Aerts R; Bevers S; Beuselinck K; Schauwvlieghe A; Lagrou K; Maertens J
Front Cell Infect Microbiol; 2022; 12():1080921. PubMed ID: 36569194
[TBL] [Abstract][Full Text] [Related]
12. Prospective Biomarker Screening for Diagnosis of Invasive Aspergillosis in High-Risk Pediatric Patients.
Loeffler J; Hafner J; Mengoli C; Wirth C; Heussel CP; Löffler C; White PL; Ullmann AJ; Michel D; Wiegering V; Wölfl M; Schlegel PG; Einsele H; Springer J; Eyrich M
J Clin Microbiol; 2017 Jan; 55(1):101-109. PubMed ID: 27795339
[TBL] [Abstract][Full Text] [Related]
13. Defining Galactomannan Positivity in the Updated EORTC/MSGERC Consensus Definitions of Invasive Fungal Diseases.
Mercier T; Castagnola E; Marr KA; Wheat LJ; Verweij PE; Maertens JA
Clin Infect Dis; 2021 Mar; 72(Suppl 2):S89-S94. PubMed ID: 33709125
[TBL] [Abstract][Full Text] [Related]
14. Use of Galactomannan Antigen and Aspergillus DNA Real-time Polymerase Chain Reaction as Routine Methods for Invasive Aspergillosis in Immunosuppressed Children in Greece.
Vrioni G; Theodoridou K; Tsiamis C; Mavrouli M; Kapsimali V; Rigopoulos D; Tsakris A
Clin Ther; 2018 Jun; 40(6):918-924.e2. PubMed ID: 29807668
[TBL] [Abstract][Full Text] [Related]
15. Detection of galactomannan in bronchoalveolar lavage of the intensive care unit patients at risk for invasive aspergillosis.
Khodavaisy S; Hedayati MT; Alialy M; Habibi MR; Badali H
Curr Med Mycol; 2015 Mar; 1(1):12-17. PubMed ID: 28680975
[TBL] [Abstract][Full Text] [Related]
16. Utility of the serum galactomannan assay for the diagnosis of invasive aspergillosis in children with acute lymphoblastic leukemia.
Avcu G; Karapinar DY; Akinci AB; Sivis ZO; Sahin A; Bal ZS; Polat SH; Metin DY; Vardar F; Aydinok Y
Int J Infect Dis; 2017 Jan; 54():8-12. PubMed ID: 27815226
[TBL] [Abstract][Full Text] [Related]
17. EORTC/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working Group.
Bassetti M; Azoulay E; Kullberg BJ; Ruhnke M; Shoham S; Vazquez J; Giacobbe DR; Calandra T
Clin Infect Dis; 2021 Mar; 72(Suppl 2):S121-S127. PubMed ID: 33709127
[TBL] [Abstract][Full Text] [Related]
18. Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial.
Aguado JM; Vázquez L; Fernández-Ruiz M; Villaescusa T; Ruiz-Camps I; Barba P; Silva JT; Batlle M; Solano C; Gallardo D; Heras I; Polo M; Varela R; Vallejo C; Olave T; López-Jiménez J; Rovira M; Parody R; Cuenca-Estrella M; ; ; ;
Clin Infect Dis; 2015 Feb; 60(3):405-14. PubMed ID: 25336623
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Performance of (1→3)-β-D-Glucan Alone and in Combination with
Springer J; Held J; Mengoli C; Schlegel PG; Gamon F; Träger J; Kurzai O; Einsele H; Loeffler J; Eyrich M
J Fungi (Basel); 2021 Mar; 7(3):. PubMed ID: 33810069
[TBL] [Abstract][Full Text] [Related]
20. Correlation between high-resolution computed tomography and galactomannan antigenemia in adult hematologic patients at risk for invasive aspergillosis.
Hidalgo A; Parody R; Martino R; Sánchez F; Franquet T; Giménez A; Blancas C
Eur J Radiol; 2009 Jul; 71(1):55-60. PubMed ID: 18468830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
